Әзербайжанда ең жақсы дәрігерлер — онлайн консультация алу

Dr. Farid Rafiyev is a specialist in pediatric health, gastrointestinal, general, and pancreatic surgery. He has written 21 scientific articles. He also holds a patent and has developed three practical proposals. These achievements show his dedication to improving surgical practice.

Dr. Rafiyev is a certified expert in laparoscopic surgery. He also holds the Bronze International Mini Gastric Bypass Surgeon of Excellence certification. He is a member of several leading global surgical societies. This highlights his recognition in the international medical community.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Academic degree, name, and surname: Assoc. Prof. Dr. Bahadır Topuz Activity direction: Urology Medical areas of interest:  Laser Prostate Enucleation Surgery (HoLEP, ThuFLEP)  Rezum (Water Vapor to Prostate) Surgery  Urooncology  Robotic and Laparoscopic Surgery  Andrology  Penile Prosthesis Surgeries  Infertility  Pediatric Urology Education:  Primary School – Güventürk Primary School, Kayseri, Türkiye (1989-1994)  Secondary School – Gözübüyük Secondary School, Kayseri, Türkiye (1994-1997)  High School – Melikgazi Super High School, Kayseri, Türkiye (1997-2001)  University – GATA, Gülhane Military Medical Faculty, Ankara, Türkiye (2001-2007)  Specialization – GATA Urology department, Ankara, Türkiye (2010-2015) Experience:  2007-2008: General Practitioner, GATA Intern and Course Company, Etlik, Ankara, Türkiye  2008-2010: General Practitioner, 3rd Armored Brigade Infantry Battalion, Çerkezköy, Tekirdağ, Türkiye  2010-2015: Urology Specialization Student, GATA Urology Department, Etlik, Ankara, Türkiye  2015-2016: Urology Specialist, GATA Urology Department, Etlik, Ankara, Türkiye  2016-2022: Urology Specialist, Gülhane Training and Research Hospital, Department of Urology, Etlik, Ankara, Türkiye  2022-2023: Associate Professor Doctor, Urology Specialist, Gülhane Training and Research Hospital, Department of Urology, Etlik, Ankara, Türkiye  2023-Present: Private Urology Center, Şişli, Istanbul, Türkiye and Liv Bona Dea Hospital, Baku, Azerbaijan 

Academic degree, name and surname: Assoc.Prof.Dr.Murat Zor Activity direction: Urology Medical areas of interest:  Urooncology  Robotic Urology and Endourology  Laser Technologies and Laser Prostate Surgeries (HoLEP, ThuFLEP)  MRI Transrectal/Transperineal Ultrasonography Prostate Fusion Biopsy  Endoscopic Stone Surgery Education:  Gülhane Military Medical Academy Experience:  Liv Ulus Hospital  Kolan International Hospital  Gülhane Training and Research Hospital  Gülhane Military Medical Faculty  University of Health Sciences, Gülhane Faculty of Medicine Memberships:  Turkish Association of Urology  Endourological Association  European Association of Urology (EAU)  American Urological Association (AUA)  Endourological Society Awards: Turkish 

Dr. Sevinc Serdarli is a specialist in gynecology and obstetrics with 11 years of experience. She focuses on in vitro fertilization, intrauterine insemination, gynecological ultrasound, colposcopy, and advanced gynecological surgeries.

She graduated from Azerbaijan Medical University. She completed her specialization at Health Sciences University in Istanbul. Dr. Serdarli has published research on tumor markers, psychological screening in childbirth, and diagnostics in pelvic inflammatory disease.

She is a member of the Turkish Medical Association and the Istanbul Medical Chamber. She has also completed accredited courses in laparoscopy, ovulation induction, and IVF.

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.